BioCardia, Inc. SEC filings BCDA
BioCardia, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Sep 27, 2007. Its latest annual report, Form 10-K, was filed on Mar 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 18, 2025 | — |
| CORRESP | Letter to the SEC | Sep 17, 2025 | — |
| CORRESP | Letter to the SEC | Sep 16, 2025 | — |
| EFFECT | Filing | Jul 17, 2025 | — |
| EFFECT | Filing | Jul 17, 2025 | — |
| CORRESP | Letter to the SEC | Jul 15, 2025 | — |
| CORRESP | Letter to the SEC | Jul 15, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 14, 2025 | — |
| UPLOAD | Letter from the SEC | May 5, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 20, 2025 | — |
| DRS | Filing | Mar 17, 2025 | — |
| EFFECT | Filing | Aug 29, 2024 | — |
| CORRESP | Letter to the SEC | Aug 29, 2024 | — |
| CORRESP | Letter to the SEC | Aug 29, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 16, 2024 | — |
| 25-NSE | Delisting notice | Aug 2, 2024 | — |
| EFFECT | Filing | Apr 1, 2024 | — |
| CORRESP | Letter to the SEC | Mar 28, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 16, 2024 | — |
| EFFECT | Filing | Dec 5, 2023 | — |
| CORRESP | Letter to the SEC | Dec 1, 2023 | — |
| CORRESP | Letter to the SEC | Nov 15, 2023 | — |
| CORRESP | Letter to the SEC | Nov 14, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 24, 2023 | — |
| EFFECT | Filing | Dec 22, 2022 | — |
| CORRESP | Letter to the SEC | Dec 20, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2022 | — |
| EFFECT | Filing | Oct 20, 2020 | — |
| CORRESP | Letter to the SEC | Oct 19, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 15, 2020 | — |
| EFFECT | Filing | Jun 16, 2020 | — |
| CORRESP | Letter to the SEC | Jun 15, 2020 | — |
| CORRESP | Letter to the SEC | Jun 15, 2020 | — |
| EFFECT | Filing | Apr 21, 2020 | — |
| NT 10-K | Form nt 10-k | Mar 31, 2020 | Dec 31, 2019 |
| UPLOAD | Letter from the SEC | Feb 20, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 17, 2019 | — |
| CORRESP | Letter to the SEC | Dec 5, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 25, 2019 | — |
| NT 10-Q | Form nt 10-q | Nov 15, 2019 | Sep 30, 2019 |
| POS EX | Form pos ex | Aug 5, 2019 | — |
| EFFECT | Filing | Aug 2, 2019 | — |
| CORRESP | Letter to the SEC | Aug 1, 2019 | — |
| CORRESP | Letter to the SEC | Aug 1, 2019 | — |
| CERT | Filing | Jul 30, 2019 | — |
| CORRESP | Letter to the SEC | Jul 24, 2019 | — |
| CORRESP | Letter to the SEC | Jul 24, 2019 | — |
| 8-A12B | Form 8-a12b | Jul 23, 2019 | — |
| CORRESP | Letter to the SEC | Jul 23, 2019 | — |
| CORRESP | Letter to the SEC | Jul 23, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 17, 2019 | — |
| NT 10-K | Form nt 10-k | Apr 2, 2019 | Dec 31, 2018 |
| D | Filing | Jan 7, 2019 | — |
| EFFECT | Filing | Sep 1, 2017 | — |
| UPLOAD | Letter from the SEC | Sep 1, 2017 | — |
| CORRESP | Letter to the SEC | Aug 31, 2017 | — |
| CORRESP | Letter to the SEC | Aug 25, 2017 | — |
| CORRESP | Letter to the SEC | Aug 8, 2017 | — |
| UPLOAD | Letter from the SEC | Aug 4, 2017 | — |
| CORRESP | Letter to the SEC | Jul 20, 2017 | — |
| UPLOAD | Letter from the SEC | Jul 13, 2017 | — |
| CORRESP | Letter to the SEC | Jun 28, 2017 | — |
| UPLOAD | Letter from the SEC | Jun 15, 2017 | — |
| DEFR14A | Form defr14a | May 3, 2017 | — |
| CT ORDER | Filing | Nov 14, 2016 | — |
| D | Filing | Nov 4, 2016 | — |
| SC 14F1 | Schedule 14f | Oct 7, 2016 | — |
| NT 10-Q | Filing | Nov 15, 2011 | Sep 30, 2011 |
| DEFM14C | Filing | May 13, 2011 | — |
| UPLOAD | Letter from the SEC | May 13, 2011 | — |
| PRER14C | Filing | May 5, 2011 | — |
| UPLOAD | Letter from the SEC | Apr 21, 2011 | — |
| PRER14C | Filing | Apr 11, 2011 | — |
| CORRESP | Letter to the SEC | Apr 11, 2011 | — |
| UPLOAD | Letter from the SEC | Mar 18, 2011 | — |
| PRER14C | Filing | Mar 9, 2011 | — |
| CORRESP | Letter to the SEC | Mar 9, 2011 | — |
| UPLOAD | Letter from the SEC | Feb 25, 2011 | — |
| PREM14C | Filing | Jan 31, 2011 | — |
| NT 10-Q | Filing | Nov 16, 2010 | Sep 30, 2010 |
| UPLOAD | Letter from the SEC | Sep 21, 2010 | — |
| CORRESP | Letter to the SEC | Sep 20, 2010 | — |
| CORRESP | Letter to the SEC | Sep 9, 2010 | — |
| UPLOAD | Letter from the SEC | Sep 8, 2010 | — |
| CORRESP | Letter to the SEC | Aug 12, 2010 | — |
| UPLOAD | Letter from the SEC | Jul 19, 2010 | — |
| EFFECT | Filing | Apr 23, 2010 | — |
| EFFECT | Filing | Feb 16, 2010 | — |
| EFFECT | Filing | Jan 6, 2010 | — |
| D | Filing | Dec 16, 2009 | — |
| D | Filing | Oct 13, 2009 | — |
| UPLOAD | Letter from the SEC | Aug 6, 2009 | — |
| CORRESP | Letter to the SEC | Jul 31, 2009 | — |
| UPLOAD | Letter from the SEC | Jun 29, 2009 | — |
| CORRESP | Letter to the SEC | Jun 4, 2009 | — |
| UPLOAD | Letter from the SEC | Apr 15, 2009 | — |
| UPLOAD | Letter from the SEC | Feb 24, 2009 | — |
| CORRESP | Letter to the SEC | Jan 30, 2009 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2008 | — |
| REGDEX | Auto-generated paper document | Sep 12, 2008 | — |
| SC 14F1 | Clicknsettle.com, inc. | Sep 9, 2008 | — |
| SC 14F1/A | Clicknsettle.com, inc. | Oct 19, 2007 | — |
| SC 14F1 | Clicknsettle.com, inc. | Oct 2, 2007 | — |
Showing 103 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BCDA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Sunnyvale, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 925741
- Former names
- Tiger X Medical, Inc. (until Oct 17, 2016); Cardo Medical, Inc. (until May 25, 2011); CLICKNSETTLE COM INC (until Oct 20, 2008); NAM CORP (until Mar 29, 2000)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.